Curbstone Financial Management Corp reduced its stake in CVS Health Corporation (NYSE:CVS) by 0.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,423 shares of the pharmacy operator’s stock after selling 70 shares during the quarter. Curbstone Financial Management Corp’s holdings in CVS Health Corporation were worth $839,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in CVS. LSV Asset Management raised its stake in CVS Health Corporation by 44.2% in the first quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock valued at $359,523,000 after purchasing an additional 1,404,384 shares in the last quarter. Swiss National Bank raised its stake in CVS Health Corporation by 26.9% in the first quarter. Swiss National Bank now owns 3,826,410 shares of the pharmacy operator’s stock valued at $300,373,000 after purchasing an additional 811,100 shares in the last quarter. Karp Capital Management Corp purchased a new stake in CVS Health Corporation in the first quarter valued at approximately $55,824,000. Thornburg Investment Management Inc. raised its stake in CVS Health Corporation by 31.8% in the first quarter. Thornburg Investment Management Inc. now owns 2,712,089 shares of the pharmacy operator’s stock valued at $212,899,000 after purchasing an additional 654,058 shares in the last quarter. Finally, Clearbridge Investments LLC raised its stake in CVS Health Corporation by 6.8% in the first quarter. Clearbridge Investments LLC now owns 9,258,404 shares of the pharmacy operator’s stock valued at $726,785,000 after purchasing an additional 589,646 shares in the last quarter. 81.55% of the stock is currently owned by institutional investors and hedge funds.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.64% during mid-day trading on Friday, reaching $83.17. The company had a trading volume of 7,483,230 shares. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $90.85. The firm has a 50-day moving average price of $78.92 and a 200-day moving average price of $78.97. The stock has a market capitalization of $84.55 billion, a price-to-earnings ratio of 16.57 and a beta of 0.92.

CVS Health Corporation (NYSE:CVS) last released its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. The firm had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.32 EPS. Equities analysts expect that CVS Health Corporation will post $5.88 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This story was reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another site, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The original version of this story can be read at https://www.dailypolitical.com/2017/09/16/cvs-health-corporation-cvs-position-trimmed-by-curbstone-financial-management-corp.html.

In other CVS Health Corporation news, CFO David M. Denton sold 237,078 shares of the company’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.65, for a total value of $18,883,262.70. Following the transaction, the chief financial officer now owns 141,096 shares of the company’s stock, valued at approximately $11,238,296.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Helena Foulkes sold 20,332 shares of the company’s stock in a transaction on Monday, June 19th. The shares were sold at an average price of $76.98, for a total value of $1,565,157.36. Following the completion of the transaction, the executive vice president now directly owns 59,300 shares in the company, valued at approximately $4,564,914. The disclosure for this sale can be found here. Insiders sold a total of 611,660 shares of company stock worth $49,492,596 in the last ninety days. 0.61% of the stock is currently owned by corporate insiders.

A number of brokerages recently weighed in on CVS. Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 target price on the stock. in a research note on Monday, June 12th. Guggenheim reaffirmed a “buy” rating on shares of CVS Health Corporation in a research note on Monday, July 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of CVS Health Corporation in a research note on Sunday, September 10th. Citigroup Inc. lowered their target price on shares of CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Thursday, August 17th. Finally, BidaskClub cut shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a research report on Friday, August 25th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the stock. CVS Health Corporation has a consensus rating of “Buy” and a consensus price target of $90.35.

CVS Health Corporation Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.